Aurengo A, Savoie F, Leger A F, Savoie J C
J Nucl Med. 1983 Dec;24(12):1143-8.
Defective iodotyrosine deiodinase activity may benefit from a specific treatment, thus requiring an unequivocal diagnosis. In reported cases this diagnosis has been obtained from an in vivo deiodination test making use of di-iodotyrosine (DIT) labeled either with I-131 or I-125. Dosimetric calculation indicates that such tests may result in unacceptable irradiation of the thyroid of a child wrongly suspected of having defective iodotyrosine deiodinase activity; therefore other methods are needed. The use of I-123 DIT is shown to be feasible, but even a 1:30 reduction in the thyroid dose still remains too high. Suppression of thyroid I- uptake by ClO4-, together with I-125 DIT, eliminates almost all thyroid irradiation and provides a sensitive, harmless, and rapid test.
碘酪氨酸脱碘酶活性缺陷可能从特定治疗中获益,因此需要明确诊断。在已报道的病例中,该诊断是通过利用用I-131或I-125标记的二碘酪氨酸(DIT)进行的体内脱碘试验获得的。剂量计算表明,此类试验可能会对被错误怀疑碘酪氨酸脱碘酶活性缺陷的儿童甲状腺造成不可接受的辐射;因此需要其他方法。已证明使用I-123 DIT是可行的,但即使甲状腺剂量降低1:30仍然过高。ClO4-抑制甲状腺对碘的摄取,再加上I-125 DIT,几乎消除了所有甲状腺辐射,并提供了一种灵敏、无害且快速的检测方法。